• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Entegris Issues Statement

Share:

April 15, 2019

Entegris, Inc., a leader in specialty chemicals and advanced materials solutions for the microelectronics industry, today issued the following statement regarding Versum Material’s determination that Merck KGaA’s revised proposal constitutes a Superior Proposal under the terms of the previously announced merger agreement with Entegris:

Entegris has considered its options and does not currently intend to propose to revise the terms of the Entegris-Versum merger of equals.

Date: April 15, 2019

Source: Yahoo Finance

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Propolis Market 2022 Extent USD 897% Billion By 2027 | Growing at CAGR of 5.46% | Insights and Forecast 2027 | No of Page 110Propolis Market 2022 Extent USD 897% Billion By 2027 | Growing at CAGR of 5.46% | Insights and Forecast 2027 | No of Page 110
  • AppliedVR Clears Major Regulatory Hurdle to Use Virtual Reality to Treat Chronic PainAppliedVR Clears Major Regulatory Hurdle to Use Virtual Reality to Treat Chronic Pain
  • Lundbeck Buys Alder for $2 Billion, Eyes ‘Blockbuster’ Migraine TherapyLundbeck Buys Alder for $2 Billion, Eyes ‘Blockbuster’ Migraine Therapy
  • Nursing Staffing Platform Intelycare Scores $45M in Funding, Debt FinancingNursing Staffing Platform Intelycare Scores $45M in Funding, Debt Financing
  • Thermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BDThermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BD
  • Using Analytics Could be Key to Curbing Medical BiasUsing Analytics Could be Key to Curbing Medical Bias
  • Essa Pharma Down 17% After Closing of Realm MergerEssa Pharma Down 17% After Closing of Realm Merger
  • Turnstone Biologics Acquires Novel Cell Therapy PlatformTurnstone Biologics Acquires Novel Cell Therapy Platform

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications